Bay­er says no breakup ‘for now,’ fo­cus­es in­stead on fix­ing ‘bad­ly bro­ken’ ar­eas 

Bay­er isn’t ready to break up its phar­ma, con­sumer and crop sci­ence di­vi­sions just yet. In­stead, CEO Bill An­der­son wants to fo­cus on tack­ling the Ger­man con­glom­er­ate’s four cur­rent chal­lenges over the next two to three years and cre­at­ing “strate­gic flex­i­bil­i­ty” for the fu­ture.

“In short, on the ques­tion of struc­ture, our an­swer is ‘not now’ — and this shouldn’t be mis­un­der­stood as ‘nev­er,’” An­der­son said in a pre­pared speech at the com­pa­ny’s fi­nan­cial news con­fer­ence, where it shared full-year 2023 earn­ings. “Of course, we will keep an open mind.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER